AI is transforming cancer drug discovery processes by enhancing target identification, drug design, and clinical trials using machine learning algorithms to analyze biomarkers. This technology promises to expedite the development of effective treatments, making a significant impact on healthcare systems globally.

Read More:

• 🔗 oncodaily.com